Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India
Isoniazid is the most commonly used drug for treatment of tuberculosis, and is administered individually or in combination with other drugs as standard first line therapy. Offsetting its efficacy, severe adverse effects, especially peripheral neuropathy and hepatotoxicity, are associated with isonia...
Saved in:
Main Authors: | Faisal Imam (Author), Manju Sharma (Author), Khalid Umer Khayyam (Author), Mohammad Rashid Khan (Author), Mohammad Daud Ali (Author), Wajhul Qamar (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Epidemiological Determinants in Tuberculosis Patients Receiving DOTS under RNTCP
by: Mayank jain, et al.
Published: (2017) -
First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi
by: Vithal Prasad Myneedu, et al.
Published: (2019) -
Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
by: Faisal Imam, et al.
Published: (2020) -
Recent advances in multi-drug-resistant tuberculosis and RNTCP
by: Grover Gagandeep, et al.
Published: (2008) -
Knowledge, Attitude and Practice of Dots Providers Under RNTCP in Ujjain, Madhya Pradesh
by: Mayank Jain, et al.
Published: (2012)